Degenerative Myelopathy in Dogs: Welfare and Support

Canine degenerative myelopathy is a progressive neurological disease causing hind limb weakness and eventual paralysis. Supportive care focused on quality of life is the cornerstone of management.

Key Facts

Degenerative myelopathy (DM) is a progressive spinal cord disease in older dogs
German Shepherds, Pembroke Welsh Corgis, Boxers, and Chesapeake Bay Retrievers are most affected
DM begins with subtle weakness and wobbliness in the hind limbs, progressing to complete paralysis
There is no effective treatment to slow progression, but physical therapy maintains function longer
A genetic mutation in the SOD1 gene is associated with DM risk
Most dogs progress from onset to non-ambulatory within 6-18 months

Welfare Considerations

DM causes progressive loss of function without pain in the early stages -- dogs typically remain bright and interested in life even as mobility deteriorates. The welfare challenge is managing the physical consequences of paralysis: pressure sores, urinary tract infections from incontinence, and reduced ability to interact with the environment. Wheelchairs allow affected dogs to remain mobile and engaged. Physical therapy slows functional decline. As disease progresses to front limb involvement and dysphagia, quality of life deteriorates rapidly. Honest, ongoing quality of life assessment guides decisions about supportive care intensity and timing of euthanasia.

What You Can Do

Implement physical therapy early after DM diagnosis to maintain mobility longer
Consider a dog wheelchair for hind limb paralysis while front limb function remains
Manage pressure sores, bladder care, and hygiene with dedication and veterinary guidance
Use quality of life assessment tools regularly to guide treatment decisions
Genetic test potential breeding dogs to reduce DM prevalence in affected breeds